- Open Access
Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research volume 35, Article number: 102 (2016)
- The original article was published in Journal of Experimental & Clinical Cancer Research 2016 35:85
Unfortunately, the original version of this article  did not include any funding information in the “Acknowledgements” section. The complete “Acknowledgements” section is included in full in this erratum.
Huang XY, Huang ZL, Xu B, Chen Z, Re TJ, Zheng Q, Tang ZY, Huang XY. Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma. J Exp Clin Cancer Res. 2016;35(1):85. doi:10.1186/s13046-016-0361-8.
The authors acknowledge the contribution of all investigators at all participating study sites. We thank Dr. Ju-Hong Yang, Metabolic Disease Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University (Tianjin, People’s Republic of China), for expert technical assistance with statistical analysis. This study was supported by grants from the National Natural Science Foundation of China (No. 81272401), the International Foundation of Translational Medicine for Abroad Scholars and Students, U.S. and China (No.UCTMP2015-03C001), the Foundation of Shanghai Health Bureau, Shanghai, PR China (No. 2012QJ001A). Z.C. acknowledges the support from the Society in Science-Branco Weiss fellowship administered by ETH Zürich and National Institute of Health/National Cancer Institute (Grant number 1U01CA202123-01, Subaward number 113098–5093073).
The online version of the original article can be found under doi:10.1186/s13046-016-0361-8.
About this article
Cite this article
Huang, X., Huang, Z., Xu, B. et al. Erratum to: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma. J Exp Clin Cancer Res 35, 102 (2016). https://doi.org/10.1186/s13046-016-0373-4